Skip to main content
logo
MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
11.98
-0.20 (-1.64%)
At close: Aug 11, 2026, 4:00 PM EDT
12.00
+0.02 (0.17%)
After-hours: Aug 11, 2026, 7:54 PM EDT

MapLight Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Cap
543774---
Market Cap Growth
-----
Enterprise Value
238.72474.2000
Last Close Price
11.9817.57---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
1.351.69---
P/TBV Ratio
0.590.33---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.010.05--
Net Debt / Equity Ratio
-0.76-0.650.53--
Net Debt / EBITDA Ratio
1.451.781.24--
Net Debt / FCF Ratio
1.852.161.28--
Quick Ratio
21.7118.806.83--
Current Ratio
22.9120.017.20--
Return on Equity (ROE)
-46.49%-56.19%-134.69%--
Return on Assets (ROA)
-46.76%-54.86%-121.16%--
Return on Invested Capital (ROIC)
-165.14%-185.64%-718.40%--
Return on Capital Employed (ROCE)
-48.41%-57.88%-137.11%--

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Buyback Yield / Dilution
-2509.30%-1079.16%-11.60%92.95%-
Total Shareholder Return
-2509.30%-1079.16%-11.60%92.95%-
SEC Filings: 10-K · 10-Q